The cdODN-SOC tested in this study is potentially applicable to a wide spectrum of cancers, as the target transcription factors/pluripotency maintaining factors Sox2, Oct4 and c-Myc are not cell/tissue specific; they are overexpressed in SP cells of various origins [10,15,34–40]. This evidence concerns the gene SOX2 and cancer.